Multivariate analysis of prognostic factors in patients with lung cancer

Frontiers in Oncology

Oncology

Minting Ma¹  Xuetao Zhou²  Changjiang Liu²  Zefeng Zhang²  Yang Guo² 

[1] Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China;Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China;

关键词: lung cancer;    prognosis;    multivariate analysis;    age;    sex;   

DOI  :  10.3389/fonc.2023.1022862

 received in 2022-08-19, accepted in 2023-01-16,  发布年份 2023

来源: Frontiers

【 摘 要 】

ObjectiveLung cancer is the leading cause of cancer-related mortality in China. The purpose of this study was to determine the effect of non-therapeutic and therapeutic factors of patients with lung cancer on survival rate.MethodsIn this retrospective study, a total of 458 patients diagnosed as lung cancer at the Department of Thoracic Surgery, the Fourth Affiliated Hospital of Hebei Medical University from September 2008 to October 2013 were enrolled. The COX proportional hazards model was used to analyze the possible factors affecting the survival of patients. Model variables included age, sex, family history, smoking, tumor location, pathological type, stage, chemotherapy, radiotherapy, operation, and targeted therapy.ResultsThe median survival time (MST) was 32.0 months (95% CI: 29.0-34.0 months), while the 1-, 3-, and 5-year survival rates were 70.74%, 36.90%, and 30.13%, respectively. The univariate analysis showed that stage, chemotherapy, radiotherapy, and operation significantly affected the median survival time of patients. Multivariate cox regression analysis suggested that sex (female vs male, 2.096, 95% CI: 1.606-2.736), stage (stage I vs IV, 0.111, 95% CI: 0.039-0.314; stage II vs IV, 0.218, 95%CI: 0.089-0.535), chemotherapy (no vs yes, 0.469, 95% CI: 0.297-0.742), and operation (no vs yes, 2.667, 95% CI: 1.174-6.055) were independently associated with the survival of patients with lung cancer.ConclusionOur study showed that male, early stage, operation were protective factors for the survival of patients, while female, advanced stage, chemotherapy were risk factors for the survival of patients. Larger studies are required to address the usefulness of these prognostic factors in defining the management of patients with lung cancer.

【 授权许可】

Unknown   
Copyright © 2023 Liu, Ma, Zhou, Zhang and Guo